DANIELLE SWEENEY to Double-Blind Method
This is a "connection" page, showing publications DANIELLE SWEENEY has written about Double-Blind Method.
Connection Strength
0.443
-
Convalescent Plasma and Coronavirus Disease 2019: Time for Reassessment. Crit Care Med. 2021 07 01; 49(7):1182-1186.
Score: 0.140
-
The last breath for inhaled antibiotics and VAP? Not so fast. Lancet Infect Dis. 2020 03; 20(3):265-266.
Score: 0.125
-
Temporal Improvements in COVID-19 Outcomes for Hospitalized Adults: A Post Hoc Observational Study of Remdesivir Group Participants in the Adaptive COVID-19 Treatment Trial. Ann Intern Med. 2022 12; 175(12):1716-1727.
Score: 0.038
-
Baricitinib versus dexamethasone for adults hospitalised with COVID-19 (ACTT-4): a randomised, double-blind, double placebo-controlled trial. Lancet Respir Med. 2022 09; 10(9):888-899.
Score: 0.037
-
Efficacy of interferon beta-1a plus remdesivir compared with remdesivir alone in hospitalised adults with COVID-19: a double-bind, randomised, placebo-controlled, phase 3 trial. Lancet Respir Med. 2021 12; 9(12):1365-1376.
Score: 0.036
-
Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19. N Engl J Med. 2021 03 04; 384(9):795-807.
Score: 0.034
-
Remdesivir for the Treatment of Covid-19 - Final Report. N Engl J Med. 2020 11 05; 383(19):1813-1826.
Score: 0.033